Psychology Commons^™

P300 Latency In Alzheimer’S Disease: A Meta-Analysis And Meta-Regression, David Payne Bennett, Dawson Hedges

Journal of Undergraduate Research

Developing a biomarker for accurate assessment and detection of Alzheimer’s disease was the goal of our research. The P300 component of the event-­‐related potential has been indicated to apparently change with the progression of Alzheimer’s disease. As measuring the P300 is non-­‐invasive and relatively easy, we sought to investigate abnormalities in the latency of the P300 in probable Alzheimer’s disease compared to healthy controls. Should such abnormalities be present, they would constitute a strong foundation for clinically significant biomarkers.